Please use this identifier to cite or link to this item:
|Title:||Angiotensin-converting enzyme in macro- and microvessels of the rat.||Austin Authors:||Jandeleit, K;Jackson, B ;Perich, R;Paxton, D;Johnston, Colin I||Affiliation:||University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||1-May-1991||Publication information:||Clinical and Experimental Pharmacology & Physiology; 18(5): 353-6||Abstract:||1. Angiotensin-converting enzyme (ACE) was measured in the aorta, cerebral and mesenteric microvessels of Wistar-Kyoto rats using a specific radioligand assay. 2. Ligand binding studies revealed a four-fold increase in concentration of ACE in mesenteric microvessels, compared with aorta or brain microvessels. The dissociation constant (Kd) was similar in all tissues. 3. The effects of oral administration of the ACE inhibitor S9650 on vascular ACE in vivo were measured. 4. S9650 produced a dose-dependent inhibition of vascular ACE from brain and mesenteric microvessels.||Gov't Doc #:||1648462||URI:||http://ahro.austin.org.au/austinjspui/handle/1/10094||URL:||https://pubmed.ncbi.nlm.nih.gov/1648462||Type:||Journal Article||Subjects:||Angiotensin-Converting Enzyme Inhibitors.pharmacology
Bicyclo Compounds, Heterocyclic
Rats, Inbred WKY
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 25, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.